Related Experiment Videos
Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy
B Cederholm1, J Wieslander, P Bygren
1Department of Nephrology, University Hospital, Lund, Sweden.
Summary
In primary IgA nephropathy, IgA antibodies bind to collagens via fibronectin complexes. Removing fibronectin from serum is crucial for accurately identifying anti-collagen antibodies in IgA nephropathy research.
Area of Science:
- Immunology
- Nephrology
- Biochemistry
Background:
- Primary IgA nephropathy is characterized by IgA antibodies that bind to collagens I, II, and IV.
- The mechanism of this binding and the role of circulating factors are not fully understood.
Purpose of the Study:
- To elucidate the mechanism by which IgA antibodies in IgA nephropathy bind to collagens.
- To investigate the role of fibronectin in mediating this interaction.
- To establish optimal methods for identifying anti-collagen antibodies in patient serum.
Main Methods:
- Isolation of IgA-fibronectin complexes from patient serum using affinity chromatography (gelatin-Sepharose, heparin-Sepharose) and anti-human IgA adsorption.
- Detection of fibronectin and IgA antibodies in isolated complexes via ELISA, gel electrophoresis, and immunostaining.
Main Results:
- IgA antibodies from IgA nephropathy patients bind to collagens I, II, and IV.
- This binding is mediated by the collagen-binding site of fibronectin, forming circulating IgA-fibronectin complexes.
- No direct antibody binding to collagen was observed; fibronectin acts as a bridge.
- The presence of IgA-fibronectin complexes in serum necessitates fibronectin removal for accurate anti-collagen antibody detection.
Conclusions:
- Fibronectin plays a critical role in mediating the binding of IgA antibodies to collagens in IgA nephropathy.
- Circulating IgA-fibronectin complexes are key players in the pathogenesis of IgA nephropathy.
- Accurate identification of anti-collagen antibodies requires pre-treatment of serum to remove fibronectin.